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Abstract.  Cultured human fetal lung fibroblasts pro- 
duce some chondroitin  sulfate proteoglycans that are 
extracted as an aggregate in chaotropic buffers contain- 
ing 4  M  guanidinium  chloride.  The aggregated pro- 
teoglycans are excluded from Sepharose CIAB and 2B, 
but become included,  eluting with a K~ value of 0.53 
from Sepharose CIAB, when Triton X-100 is included 
in the buffer. Conversely, some of the detergent- 
extractable chondroitin  sulfate proteoglycans can be 
incorporated into liposomes, suggesting the existence 
of a hydrophobic membrane-intercalated  chondroitin 
sulfate proteoglycan fraction.  Purified preparations of 
hydrophobic chondroitin sulfate proteoglycans contain 
two major core protein forms of 90 and 52 kD. A 
monoclonal antibody (F58-7D8) obtained from the fu- 
sion of myeloma cells with spleen cells of BALB/c 
mice that were immunized with hydrophobic pro- 
teoglycans recognized the 90- but not the 52-kD core 
protein.  The epitope that is recognized by the antibody 
is exposed at the surface of cultured human lung 
fibroblasts and at the surface of several stromal cells 
in vivo, but also at the surface of Kupffer cells and 
of epidermal cells. The core proteins of these small 
membrane-associated chondroitin  sulfate proteoglycans 
are probably distinct from those previously identified 
in human fibroblasts by biochemical,  immunological, 
and molecular biological approaches. 
C 
ULTURED human fibroblasts  produce several distinct 
chondroitin  sulfate  proteoglycans  (CSPGs) ~ (5,  6, 
37). These CSPGs differ in overall size, relative gluc- 
uronic acid/iduronic acid content,  and distribution  between 
culture compartments (7). Some have been characterized  in 
considerable detail. 
The very large CSPGs from the fibroblast  matrix  harbor 
large  core proteins that  interact  with hyaluronic  acid (22, 
33), which is reminiscent  of the properties of the large ag- 
gregating  cartilage  proteoglycans  (17). The  large  CSPGs 
from fibroblasts and from cartilage can be distinguished  im- 
munochemically (22),  but comparative peptide maps show 
also structural similarities  (20). Recent cDNA sequence data 
imply  that  the  carboxy-terminal  ends  of a  large  human 
fibroblast  CSPG and of the large  aggregating  rat cartilage 
CSPG are strongly homologous, containing  sequences with 
lectin-like and growth factor-like structural features (10, 25). 
Cultured human fibroblasts  also secrete some small idur- 
onic acid-rich proteoglycans  characterized  by ,'o40-kD core 
proteins (2,  14). Immunological  and peptide mapping  data 
suggest that these small proteoglycans are related to small in- 
terstitial CSPGs with 50-40-kD core proteins that can be iso- 
1.  Abbreviations  used in  this  paper:  CS,  chondroitin sulfate;  CSPG(s), 
chondroitin  sulfate  proteoglycan(s);  GdnHCI,  guanidine  hydrochloride; 
HSPG(s), heparan sulfate proteoglycan(s). 
lated from a number of different tissues (20, 30). These small 
CSPGs accumulate in the extracellular  matrix during culture 
on collagen  supports  (11) and in vivo, where they occur in 
close association  with fibrous structures  (39). In vitro, they 
bind to fibronectin  (35) and to collagen  (34) through  their 
core proteins, affect collagen fibril formation (38), and mod- 
ulate the adhesion  of cells to collagen-fibronectin matrices 
(26).  Recent cDNA and peptide sequence data suggest that 
these small CSPGs are synthesized by the human fibroblasts 
as preproproteins,  containing a signal peptide, a propeptide, 
and the mature core protein (24). 
However, poly- (18) and monoclonal (1) antibody probes, 
recognizing epitopes in the residual chain stubs of chondroi- 
tinase-treated  proteoglycans  or recognizing  the native  gly- 
cosaminoglycan  chains themselves,  detect also some nonfi- 
brillar chondroitin  sulfate (CS) in close association with the 
outer aspect of the plasma membrane of the fibroblasts.  Li- 
gand-induced  capping  upon incubation  of living cells with 
the antibodies  (1) and a patchy  surface distribution  of im- 
munoferritin  complexes  in electron microscopy (18) imply 
that this surface CS is free to move laterally along the plane 
of the membrane, and raise the possibility of integral mem- 
brane CSPG. 
In the present report we provide direct evidence in support 
of this proposal, and demonstrate  the occurrence of CSPGs 
at the cell surface of human  lung fibroblasts  by means of a 
monoclonal antibody probe which defines an epitope in the 
core protein  moiety of these proteoglycans. 
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Cell Culture, Fractionation, and Extraction 
Procedures 
Human lung fibroblasts were grown in Dulbecco's modified minimal essen- 
tial medium (Gibco Europe, Gent, Belgium) containing 10 % (vol/vol) new- 
born calf serum (27). Confluent cultures were labeled for 48 h with 5 #Ci 
(1.8  ×  105 Bq) of carrier free H235SO4 (New England Nuclear, Boston, 
MA) per milliliter of culture medium (27). Labeled monolayers were rinsed 
with Dulbecco's PBS before fractionation and extraction. Whole monolayers 
were extracted in 4 M guanidine hydrochloride, 10 mM N-ethylmaleimide, 
5 mM benzamidine, 50 mM sodium acetate pH 5.8 (GdnHCI buffer), sup- 
plemented with 2.5  mg/ml pepstatin A, 50 ~g/mi leupeptin, and 2  mM 
phenylmethylsulfonyl fluoride just before use (27). Plasma membrane frac- 
tions were prepared as described before (23,  27)  and extracted in 4  M 
GdnHCI buffer supplemented  as described above. Extracellular matrix frac- 
tions were prepared by sequential extraction of the monolayers with Triton 
X-100 buffer (see below), sodium deoxycholate buffer,  hypotonic Tris-HCI 
buffer and hypertonic KCI buffer as described before (19, 21, 27),  and ex- 
tracted in 4 M GdnHCI buffer.  The whole monolayer, plasma membrane, 
and matrix extracts were cleared by centrifugation (100,000 g, 30 min) be- 
fore gel filtration. In every instance, the cleared 4 M GdnHCI extract con- 
tained 95%  or more of the total 35S-chondroitin  sulfate in the fraction. 
Gel Filtration and Ion-Exchange Chromatography 
Gel filtration on (1  ×  100 cm) Sepharose CL2B and 4B (Pharmacia LKB 
Biotechnology Inc., Uppsala, Sweden) columns in 4 M GdnHC1 buffer, or 
in 4 M GdnHC1 buffer supplemented with 0.5% (wt/vol) Triton X-100, was 
performed at 40C with a flow rate of  4 ml/h. Carrier heparin and chondroitin 
sulfate (10 #g/ml) and bovine serum albumin (50/~g/ml) were included in 
the 4 M GdnHCI buffer used for chromatography, except when the sample 
was prepared for radioiodination (28). 
Ion-exchange chromatography on Mono Q (Pharmacia LKB Biotechnol- 
ogy Inc.) in urea buffer (0.5%  Triton X-100, 6 M urea, 50 mM Tris-HCl 
pH 8.0) with a (0-1.2 M) linear NaC1 gradient was as described before (8). 
Glycosaminoglycan Identification 
Aliquots of the eluted fractions were digested with protease K  (Merck, 
Darmstadt,  FRG)  and  ethanol  precipitated.  Ethanol-insoluble protease- 
resistant label which became ethanol soluble after chondroitinase ABC 
(Miles Laboratories Inc., Naperville, IL) digestion was defined as chondroi- 
tin  sulfate  (8).  The  remaining chondroitinase ABC-resistant label  was 
identified as heparan sulfate previously (27).  For digestions with chon- 
droitinase AC (Miles Laboratories Inc.) the pH of the Tris-HC1 buffer was 
adjusted to 7.0. 
Purification of  the CSPGs 
Proteoglycans extracted from whole monolayers in Triton X-100 buffer (10 
mg/ml Triton X-100,  150 mM NaC1,  10 mM Na2HPO4,  2 mM KH2PO4, 
5 mM N-ethylrnaieimide, 5 mM benzamidine, 1 mM phenylmethylsulfonyl 
fluoride, and 1 t~g/ml of pepstatin A, pH 7.4), were concentrated by absorp- 
tion on DEAE-Trisacryi M, eluted in 4 M GdnHCI buffer containing 0.5% 
Triton X-100, and fractionated over Sepharose CLAB in 4 M GdnI-IC! con- 
taining 0.5%  Triton X-100.  Fractions containing 35S-chondroitin  sulfate 
were pooled, dialyzed against urea buffer, and submitted to ion-exchange 
chromatography on Mono Q  The eluted 35S-chondroitin  sulfate was reab- 
sorbed on Mono Q, rinsed with urea buffer containing 50 mM octylgluco- 
side instead of Triton X-100, and eluted in 4 M GdnHCI buffer supplemented 
with 50 mM octylglucoside. After the addition of 5 mg/ml of phosphatidyl 
choline, the proteoglycan sample was dialyzed against 4 M GdnHC1. Result- 
ing  proteoglycan-liposome mixtures  were  fractionated over  Sepharose 
CLAB in 4 M GdnHCI buffer, to separate hydrophobic liposome-associated 
proteoglycans from the nonhydrophobic proteoglycans and free glycosami- 
noglycan chains.  In some experiments [3H]phosphatidylcholine was in- 
cluded in the proteoglycan-phospholipid mixtures to mark the position of 
the liposomes (27). These eluted in the excluded volume of the Sepharose 
CL4B columns. Small CSPGs accumulating in the culture media of  the cells 
(2, 14) were purified by gelfiltration on Sepharose CL4B and ion-exchange 
chromatography on Mono Q as described above. 
Characterization of the Core Protein Moieties 
Purified hydrophobic CSPGs were made free of carrier and phospholipid 
by gel filtration on Sepharose CLAB in 4 M GdnHC1 buffer containing 0.5 % 
Triton X-100. Carrier-free CSPGs were t25I iodinated by the chloramine T 
method as described before (28).  125I-labeled proteoglycan was separated 
from free label by ion-exchange chromatography and gel filtration in the 
presence of detergent.  Digestion of the  ~25I-labeled proteoglycans with 
chondroitinase ABC,  or with heparitinase (Miles Laboratories Inc.), or 
with both enzymes and electrophoresis on 4-16 % polyacrylamide gradient 
gels or in 4% Nu-sieve agarose gels in the presence of SDS were as de- 
scribed before (8, 9, 28). Binding of the CSPGs and of their core proteins 
to fibrillar type I collagen was assessed as described previously (21). 
Immunochemical Procedures 
mAb F58-7D8  was obtained after immunizing BALB/c mice with partially 
purified hydrophobic proteoglycan fractions, using the standard procedures 
of immunization, cell fusion, hybrid selection, cloning, and subcloning de- 
scribed before (9).  Affinity-purified polyclonal rabbit antibodies (14,  39) 
and a mixture of murine monoclonal antibodies (LN1, LN3, LN4; reference 
35) specific for the core proteins of the small dermatan sulfate (iduronic 
acid-rich chondroitin sulfate) proteoglycans from human fibroblast secre- 
tions were kind gifts of Dr. Hans Kresse (University of Miinster, Federal 
Republic of Germany). Dot-blotted eluate fractions and Western blots on 
Zeta-probe nylon membrane (Bio-Rad Laboratories, Richmond, CA) were 
incubated with 20  #g/ml of mAb 7D8  diluted in PBS containing 0.5% 
casein, and stained using peroxidase-linked rabbit anti-mouse Ig, 3,3' di- 
aminobenzidine, and  H202  (9,  21). The polyclonal and the monoclonal 
anti-dermatan sulfate proteoglycan antibodies were used at dilutions of 
1:400  and  1:100, respectively. Coupling of mAb 7D8 to CNBr-activated 
Sepharose and immunopurification of the 125I-laboled proteoglycans were 
as described before (28). 
Histological Procedures 
Immunoperoxldase Staining of Cells and tissues for Light Microscopy. 
Cultured cells were fixed with 0.3% glntaraldehyde in 0.1 M sodiumcaco- 
dylate, pH 7.4.  mAb 7D8 was added at a concentration of 10-100  ~g/ml 
in PBS containing 1% BSA. Binding of mAb 7D8 was detected with rabbit 
anti-mouse peroxidase, diluted 1:50 in PBS-BSA, using 3,3' diaminobenzi- 
dine (0.05 %) and hydrogen peroxide (0.01%) as substrates. Tissues were fro- 
zen in liquid nitrogen and cryosections (6 t~m thick) were incubated with 
mAb 7D8 (25/~g/mi) without prior fixation. 
lmmunoperoxldase and Gold Labeling for Transmission Electron Mi- 
croscopy. Cryosections were immediately fixed for 20 rain with 2% acrolein 
in phosphate buffer at 4°C, and incubated with mAb 7D8 (100/~g/ml).  After 
the immunogold labeling (5-nm gold-tagged goat anti-mouse IgG, diluted 
1:10, overnight) or the immunoperoxidase labeling (peroxidase-conjugated 
rabbit anti-mouse IgG, diluted 1:50, 1 h), a second fixation with 3% glutar- 
aldehyde in sodium cacodylate preceded dehydration and embedding. For 
ultracryosections cultured cells were fixed in situ with acrolein and scraped. 
Sections (,~100 nm thick) were made as described before (36) and incubated 
with mAb 7D8 (100 ~g/ml) for 1 h and with gold-coupled goat anti-mouse 
IgG. 
Gold Labeling for Scanning Electron Microscopy. Cells were allowed 
to spLf~ad for 1.5 h on a fibronectin coat and fixed with 2% acrolein for 20 
min at 4°C. After incubation with mAb 7D8 (0.5/~g/ml) and gold labeling 
with goat anti-mouse (diluted 1:40) a  silver enhancement treatment was 
performed following the instructions of Janssen Pharmaceuticals, Beerse, 
Belgium. Cells were fixed again with glutaraldehyde (3 %  ), dehydrated, crit- 
ical point dried, and covered with gold in a sputter coater (Folaron Instrn- 
ments Inc., Hatfield, PA) before viewing in a Philips PSEM 500.  To test 
whether the binding of mAb 7D8 was specific, uncoated, CSPG-coated or 
heparan sulfate proteoglycan (HSPG)-coated beauis were added during the 
incubation of  the cells with the antibody. To prepare coated beads, the cellu- 
lar CSPG and HSPG present in the detergent-extract of "ol  x  107 human 
lung flbroblasts were fractionated on a Sepbarose CIAB column (as in Fig. 
3 A). The CSPG and HSPG peaks were dialyzed against urea buffer and 
adsorbed on 200 #! packed DEAE-Trisacryl M beads. After extensive rins- 
ing with 150 mM NaCI, 20 mM Tris-C1, pH 7.4 to remove all traces of de- 
tergent, the beads were mixed with 0.5 t~g mAb 7D8 in 1 ml 150 mM NaC1, 
20 mM Tris-Cl, pH 7.4, and the mixture was added to the cells. Prior ex- 
periments had shown that rnAb 7D8 did not bind to DEAE in this buffer. 
After a 1-h incubation the mixture of beads and mAb was removed, and the 
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cessed as above. 
Results 
Integral Membrane CSPG of  Human Lung Fibroblasts 
When  4  M  GdnHCI  extracts  of continuously  35502-4-1a- 
beled fibroblast monolayers were fractionated over Sepha- 
rose CL2B, three distinct 35S-chondroitin  sulfate-containing 
peaks were obtained:  excluded materials, materials eluting 
with K,v ,00.3 and a peak eluting with K,v ,00.8 (Fig.  1 A). 
Further  experiments  indicated  that  the  excluded  fractions 
contained minor (only ,07 % of the total 35S-CS in the mono- 
layer) but specific CSPGs with properties of integral mem- 
brane molecules. First, this Sepharose CL2B-excluded 35S- 
CS became partially included when treated with 0.5 % Triton 
X-100 and rechromatographed on Sepharose CL4B  in the 
presence of detergent (Fig.  2 A).  This 4B-included 35S-CS 
eluted with K,,  =  0.53,  and was identified as proteoglycan 
by  virtue  of its  susceptibility  to  protease  K.  The  alkali 
borohydride-treated  35S-CS chains  from this  proteoglycan 
eluted with K,v =  0.69 (estimated approximate M, =  25,000, 
not  shown).  The  Sepharose CL2B-included  35S-CS peaks 
which eluted with K,v =  0.3 and with K~, =  0.8, in contrast, 
were not affected in their chromatographic behavior when 
treated with detergent (not shown). When rechromatographed 
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Figure 1. Fractionation of the culture extracts. Whole monolayers 
(A) and plasma membrane fractions (B) of cultured 35SO4-1abeled 
human lung fibroblasts were extracted in 4 M GdnHC1 and chro- 
matographed on Sepharose CL2B in the absence of detergent. Sam- 
pies were taken to determine the amount of total 35S (--) and 35S- 
CS (i) eluted in each fraction. 
on Sepharose CL4B the former eluted in the void volume of 
the column (not shown, but as in Fig.  2 B). 
Second,  in  comparison  with  whole  monolayer extracts 
(Fig. 1 A), 4 M GdnHC1 extracts of partially purified plasma 
membrane  preparations  (nearly  13-fold  enriched  in  5' 
nucleotidase, see reference 27), were enriched in Sepharose 
CL2B-excluded 35S-CS (Fig.  1 B).  The K,v 0.3  CSPGs, in 
contrast, were relatively depleted from the membranes, but 
were the predominant CSPG present in extracellular matrix 
extracts. With or without detergent, the latter were excluded 
from Sepharose CL4B (Fig. 2 B). After treatment with de- 
tergent most of the 2B-excluded membrane-associated 35S- 
CS eluted with K,v  =  0.53  from Sepharose CL4B (Fig.  2 
B),  a  result similar to that obtained for Sepharose CL2B- 
excluded materials from whole monolayer extracts (Fig. 2 A). 
Third, some 10% of the 35S-CS which could be extracted 
from human lung fibroblast monolayers with nonionic deter- 
gent and in the absence of chaotrope (Triton X-100 buffer 
extracted "070%  of the amount of 35S-CS extractable with 
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Figure 2. I~.lergent-smceptible  CS1N3 complexes. Sepl~mse CL2B-- 
excluded label originating from whole monolayer extracts (A) and 
from plasma membrane extracts (B) was treated with Triton X-100 
and rechromatographed on Sepharose CL4B in the presence of the 
detergent. Samples were taken to determine the amount of 35S-CS 
(e) eluted in each fraction. Indicating the amount of total 35S (--) 
eluted in A reveals a CS-poor peak which corresponds to the hydro- 
phobic heparan sulfate proteoglycan present in these cells (27). The 
elution of the large 35S-CSPG present in extracellular matrix prep- 
arations of the fibroblasts (0) is given in B for comparison. 
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(Fig.  3,  A  and B).  After treatment with detergent, those 
liposome-associated  35S-CSPGs  eluted  with  Kay  =  0.53 
from Sepharose CL4B (not shown). Similar results were ob- 
tained with the 35S-CSPG, isolated from 4  M  GdnHCI ex- 
tracts,  which  were  originally  excluded  from  Sepharose 
CL2B (as in Fig.  1 A) but became 4B-included after deter- 
gent treatment (as in Fig. 2 A), except that the association 
of these "detergent-susceptible" CSPG with the liposomes 
was nearly quantitative (not shown). The 35S-CSPG isolated 
from the  detergent-insoluble matrix  (tested on  Sepharose 
CL2B columns, as in reference 27), and 35S-CSPG isolated 
from conditioned culture medium, in contrast, did not as- 
sociate with liposomes (not shown).  Analysis of the chon- 
droitinase susceptibility of the glycosaminoglycan chains in- 
dicated  that  a  specific  35S-CS fraction  of the  detergent 
extracts became liposome associated  (Fig.  4).  Chondroi- 
tinase AC-digestion of the 35S-CS chains present in the non- 
interacting materials yielded virtually no Sephadex G25-in- 
cluded label (Fig. 4, D-F). In contrast, chondroitinase AC 
converted nearly half of the label of the liposome-associated 
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Figure 3. Liposome-interacting  CSPG. Detergent extracts of 35SO4- 
labeled human lung fibroblast monolayers were fractionated on 
Sepharose CL4B in 4 M GdnHCI containing Triton X-100, yielding 
a heparan sulfate-rich peak (K,, ,00.27) and a chondroitin sulfate- 
rich peak (K,~ ,00.57) (A). The chondroitin sulfate peak was fur- 
ther purified by ion-exchange on Mono Q. After exchanging Triton 
X-100 for octylglucoside, liposomes were formed by adding phos- 
phatidylcholine and dialyzing the mixture against detergent-free 
4 M GdnHCI buffer. The liposome-CSPG  mixture was then re- 
chromatographed on Sepharose CI.,4B in the absence of detergent 
(B).  In some experiments [3H]phosphatidylcholine was included 
to trace the elution of the liposomes. 
35S-CS chains to the size of disaccharides (Fig. 4, A-C), in- 
dicative for a higher glucuronic acid content in these lipo- 
philic materials.  Analysis of the 35S-CS chains present in 
the detergent-susceptible peak of the 4 M GdnHCI extract, 
revealed a chondroitinase AC susceptibility similar to that of 
the CS chains present on the liposome-interacting materials 
of  the detergent extract (not shown). Thus, human lung fibro- 
blasts contain some distinct 35S-CSPGs which are enriched 
in plasma membrane preparations, from where they can be 
extracted with  chaotropes as  (Sepharose CL2B-excluded) 
micellar aggregates, or be solubilized with detergent. This 
requirement for detergent to obtain complete solubilization 
and their ability to interact with liposomes would identify 
these proteoglycans as integral membrane components. 
Characterization of the Integral Membrane CSPG 
Core Proteins 
These  putative  integral  membrane  CSPGs  were  purified 
from Triton X-100 extracts of the fibroblast monolayers, by 
gel filtration on Sepharose CL4B in the presence of  detergent 
(as in Fig.  3 A), ion-exchange chromatography of the 35S- 
CS peak on Mono Q (not shown), and by liposome incorpo- 
ration followed by chromatography on Sepharose CL4B in 
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Figure 4. Chondroitinase susceptibility of the CSPG. Chondroitin- 
sulfate chains  were  isolated  from  liposome-interacting (I)  35S- 
CSPG (excluded from Sepharose CL4B, as in Fig. 3 B) and from 
noninteracting (NI) materials (Sepharose CL4B included, as in Fig. 
3 B) by digestion with protease K and treatment with nitrous acid 
to insure removal of any contaminating heparan sulfate (27). I-CS 
chains (A-C) and NI-CS chains (D-F) were chromatographed on 
Sephadex (325 in 100 mM Tris-HCl, pH 8.0 without further treat- 
ment (A and B), after treatment with chondroitinase AC (B and E), 
or after treatment with chondroitinase ABC (C and F). 
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tion procedures the epitope recognized by mAb 7D8 (ob- 
tained from the immunization of BALB/c mice with mem- 
brane  proteoglycans  of  human  fibroblasts)  appeared  to 
copurify with the lipophilic CSPGs. The rnAb stained only 
dot spots derived from fractions of detergent-extracts eluting 
with K,v ,x,0.5-0.6 from Sepharose CL4B in the presence of 
detergent (Fig. 5 A); and from fractions that were excluded 
from  Sepharose  CL4B  after  liposome  incorporation  and 
chromatography of the materials in the absence of detergent 
(Fig. 5 B). Apparently, the mAb did not react with any hepa- 
ran sulfate proteoglyean (Fig. 5 A) or with non-lipophilic cel- 
lular CSPG (Fig. 5 B). It also did not react with any matrix 
or secreted PG (not shown). 
The purified lipophilic CSPGs  were radioiodinated and 
further analyzed by SDS-polyacrylamide gradient gel elec- 
trophoresis and autoradiography (Fig. 6 A). Without further 
treatment  the  ~25I-labeled proteoglycans  migrated  as  two 
broad  bands  with  apparent  molecular  mass  of  110,000- 
180,000  and  of  60,000-85,000  kD.  After  chondroitinase 
ABC-treatment two major sharp bands of 90 and 52 kD were 
obtained, together with minor bands of 130, 119, and 46 kD. 
The migration of these bands was not affected by additional 
digestion of  the CSPGs with heparitinase, indicating absence 
of heparan sulfate-chondroitin sulfate hybrid proteoglycans 
as found in other cell types (8). Omitting the reduction of 
disulfide bonds before the electrophoresis had  no distinct 
effect on the migration of the major labeled bands (not shown, 
but compare with Fig.  7 B and Fig.  8 A).  Analysis of the 
~25I-CSPG which  could  be immunopurified by adsorption 
on Sepharose-linked mAb 7D8, in contrast, yielded a broad 
110-180 kD smear without enzyme treatment, and a single 
sharp  ~90-kD  band  after chondroitinase  ABC  digestion 
(Fig. 6 B). Reduction had no effect on the migration of this 
material (not shown). 
The comparison of the immunostaining (Fig. 7 A) and of 
the autoradiography (Fig. 7 B) of Western blots of  unreduced 
chondroitinase  ABC-digested  ~25I-labeled CSPG  indicated 
that the 90-kD core was recognized by mAb 7D8. Reduction 
with/3 mereaptoethanol before electrophoresis abolished this 
recognition of the 90-kD band by mAb 7D8, without affect- 
ing  the  migration  or  the  electrotransfer of the  band  (not 
shown), suggesting that this core protein had a single subunit 
structure, with one or more internal disulfide bonds. 
In the absence of chondroitinase ABC digestion the im- 
munoreactive and the labeled materials transferred poorly 
from the polyacrylamide gradient gels (compare lanes I  and 
2 in Fig. 7, A and B). Both the digested and the undigested 
materials transferred well, however, when the electrophore- 
sis was performed in SDS-agarose gels. Both were intensely 
stained by mAb 7D8, and chondroitinase ABC digestion de- 
creased the apparent molecular mass of the immunoreactive 
materials (Fig. 7 C). This result confirmed that the 7D8 epi- 
tope was part of the CSPG core protein and exposed in the 
native molecule. 
Figure 5.  Monoclonal antibody 7D8 marks a lipophilic molecule. 
Detergent extracts of human lung fibroblasts were fractionated on 
Sepharose CL4B in 4 M GdnHCI buffer containing Triton X-100 
as in Fig. 3 A. Aliquots of the fractions (11-50) were spotted on 
Zeta-probe membrane and stained with mAb 7D8 and peroxidase- 
conjugated rabbit anti-mouse  immunoglobulins (A). The CSPG- 
and 7D8-positive fractions (28-45) were further purified, incorpo- 
rated in liposomes, and rechromatographed on Sepharose CL4B in 
the absence of detergent as in Fig. 3 B. Aliquots of the eluate frac- 
toins (11-50) were spotted on Zeta probe membrane and stained 
with mAb 7D8 and second antibody (B). 
Figure 6.  Heterogeneity of the lipophilic CSPG. (A) Purified lipo- 
some-interacting CSPGs were iodinated using Na~25I and chlora- 
mine T, and submitted to polyacrylamide gradient gel electrophore- 
sis in the presence of SDS after reduction with ~-mercaptoethanol 
and analyzed by autoradiography: nondigested CSPG (•);  chon- 
droitinase ABC-digested CSPG (2); heparitinase-digested CSPG 
(3); doubly heparitinase- and chondroitinase ABC-digested CSPG 
(4). (B) The t2SI-labeled  lipophilic CSPGs were further fraction- 
ated by affinity chromatography on Sepharose-linked mAb 7D8. 
The bound materials were eluted in 4M GdnHC1 buffer, ethanol 
precipitated,  and analyzed by SDS polyacrylamide gradient gel 
electrophoresis and autoradiography before (1) and after (2) diges- 
tion with chondroitinase ABC. 
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core protein.  Purified t25I-iodinated  liposome-interacting CSPGs 
were treated with chondroitinase ABC (lane 1) or left untreated 
(lane 2) and submitted to polyacrylamide gradient gel electrophore- 
sis in the presence of SDS, but without prior reduction of disulfide 
bonds. After electrotransfer to Zeta probe membrane, the mem- 
brane was stained with mAb 7D8 using an indirect immunoperoxi- 
dase technique (A) and submitted to autoradiography (B). Alterna- 
tively, the untreated (1) and the chondroitinase ABC-digested (2) 
liposome-interacting CSPGs were submitted to SDS-agarose gel 
electrophoresis, electroblotted on a Zeta probe membrane, and im- 
munostained with mAb 7D8 (C). 
Comparison  of  Lipophilic and Nonlipophilic  CSPGs 
The purified nonliposome-interacting CSPGs of the deter- 
gent extracts were similarly radioiodinated, and compared 
with  the  liposome-interacting  CSPGs  by  SDS-polyacryl- 
amide  gradient  gel  electrophoresis  and  autoradiography 
(Fig. 8 A). In contrast to the lipophilic CSPGs which ran as 
two separate smears if undigested or as two distinct bands 
of 90 and 52 kD after chondroitinase ABC-digestion,  the 
t25I-labeled nonlipophilic CSPGs migrated as a single broad 
band with apparent molecular mass of 70,000-100,000 kD 
before chondroitinase ABC digestion and as a closely spaced 
doublet of  46--44-kD bands after chondroitinase ABC diges- 
tion.  Some label associated with the nonlipophilic CSPGs 
resisted the digestion with chondroitinase or had a residual 
mobility similar to that of the bulk of the nonenzyme-treated 
proteoglycans, its nature remaining unclear. Whereas intact 
nonliposome-interacting CSPGs or the 46--44-kD core pro- 
teins of these proteoglycans bound to fibrillar collagen, none 
of  the  intact  or  chondroitinase  ABC-digested  lipophilic 
CSPG had collagen-binding properties (Fig. 8 B). Finally, 
dot-blot analysis (Fig. 9 A), using core protein-specific poly- 
clonal and monoclonal antibody probes raised against the 
small iduronic acid-rich CSPGs of human skin fibroblasts 
(14, 35), indicated that the nonlipophilic CSPGs of the deter- 
gent  extracts  were  immunologically  related  to  the  small 
CSPGs that were secreted in the culture medium by the cells. 
After digestion with chondroitinase ABC,  both yielded a 
doublet of  immunoreactive 46-44-kD core proteins on West- 
ern blots (Fig. 9 B). In contrast, none of these antibodies de- 
tected any of the lipophilic proteoglycans or core proteins 
(Fig. 9, A and B) and conversely, mAb 7D8 did not detect 
the nonlipophilic cellular or secreted CSPG (Fig. 9 A), under 
circumstances where each of  these proteoglycans was readily 
Figure 8. Lipophilic and nonlipophilic CSPGs contain structurally 
and functionally distinct core proteins. (A) Purified t2sI-iodinated 
lipophilic (I and 2) and nonlipophilic (3 and 4) CSPGs were treated 
with chondroitinase ABC (2 and 4) or left untreated (1 and 3) and 
submitted to polyacrylamide gradient gel electrophoresis in SDS, 
without reduction of disulfide bonds, followed by autoradiography 
of the gel. (B) Lipophilic (1 and 3) and nonlipophilic (2 and 4) 
t2SI-labeled CSPGs were digested with chondroitinase ABC or left 
untreated and tested for binding to fibrillar type I collagen. Colla- 
gen-binding chondroitinase-treated CSPGs (1 and 2) and chondroi- 
tinase-digested collagen-binding CSPGs (3 and 4) were submitted 
to polyacrylamide gradient gel electrophoresis in SDS, followed  by 
autoradiography of the gel. 
detected by its corresponding immunoprobe. Thus, lipophilic 
and nonlipophilic small CSPGs of human lung fibroblasts 
likely represent distinct molecular species. 
Cell Surface Localization  and 1Issue Distribution 
The epitope recognized by mAb 7D8 showed a specific cellu- 
lar and tissue distribution, both in vitro and in vivo. Indirect 
immunoperoxidase staining with mAb 7D8 of whole mounts 
of nonpermeabilized cultured  human  lung  fibroblasts  re- 
vealed a distinct and homogeneous staining of cell surfaces 
(Fig.  10 A). This homogeneous cell-surface distribution of 
the epitope was confirmed by scanning electron microscopy 
of silver-enhanced immunogold complexes. Except for the 
supranuclear area,  the entire surface and the finest exten- 
sions of fibroblasts spreading on fibronectin coats were heav- 
ily labeled (Fig. 10 E). This heavy labeling of  the cell surface 
was not observed on cells which had not been exposed to the 
mAb (Fig. 10 D), and was markedly inhibited by the addition 
of DEAE-bound CSPG (Fig. 10 G) during the incubation of 
the cells with the mAb, but not by the addition of DEAE- 
bound HSPG (Fig.  10 H) or by DEAE-beads only (Fig.  10 
F). Thus, most of the gold deposits were due to the specific 
binding of the monoclonal antibody to the cell surface. In- 
direct immunogold staining of frozen sections, however, in- 
dicated that the distribution of the epitope was not limited to 
the surface of the cultured fibroblast (Fig.  10 C). The label 
also decorated internal cell structures, but it was not possible 
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Immunoperoxidase and  immunogold staining of skin sec- 
tions followed by electron microscopy localized the epitope 
at the external surface of the epidermal cells (Fig. 11 D) and 
dermal fibroblasts (Fig. 11 E). Internal cell structures or ma- 
trix fibers were not decorated. In every instance the staining 
was shown to depend on the inclusion ofmAb 7D8 in the first 
incubation. These data indicate that expression of the 7D8 
epitope may show some restriction, occuring at the surface 
of human  fibroblasts and  of some  (ectodermal) epithelial 
cells. 
Figure 9. Lipophilic and nonlipophilic CSPGs contain immunologi- 
cally distinct core proteins.  (A) The lipophilic (1) and the non- 
lipophilic (2) CSPGs of the detergent extract, and the small CSPGs 
secreted in the culture medium (3) of one lung fibroblast mono- 
layer, and amounts of lipophilic CSPGs from three times as many 
cells (4) were dot-spotted on a Zeta probe membrane, and stained 
with mAb 7D8 (a); with a polyclonal affinity-purified  anti-derma- 
tan sulfate proteoglycan antibody (b), with a mixture of  three mono- 
clonal anti-dermatan  sulfate proteoglycan antibodies (c), or only 
with the peroxidase-conjugated rabbit anti-mouse antibodies (d), 
and the peroxidase-conjugated swine anti-rabbit antibodies (e) used 
in the direct immunoassay. (B) The lipophilic (1), and the non- 
lipophilic (2) CSPGs of the detergent extract and the small secreted 
CSPGs of human lung fibroblasts (3) were digested with chon- 
droitinase ABC and submitted to SDS polyacrylamide gradient gel 
electrophoresis, electroblotted  on Zeta probe membrane, and stained 
with the mixture of monoclonal anti-dermatan sulfate proteoglycan 
antibodies using an indirect immunoperoxidase assay. 
to determine whether these were membrane limited.  The 
mAb also stained the contours and surface structures of cul- 
tured human mammary epithelial HBI-100 cells (Fig. 10 B). 
Thus, the epitope is not restricted to cultured human fibro- 
blasts. 
Indirect immunoperoxidase staining and light microscopy 
of tissue sections indicated that, in situ, the 7D8 epitope oc- 
cuffed on connective tissue  and  some epithelial cells.  In 
skin,  reaction occurred in both the dermis and epidermis 
(Fig.  11 A). In the dermis the reaction was restricted to the 
cells,  In the epidermis all cell layers, except the most su- 
perficial, were stained. In liver the reaction was confined to 
the portal  spaces  and  to  some  cells  (presumably Kupffer 
cells) localized in the sinusoids,  but the hepatocytes were 
negative (Fig. 11 B). In kidney, the interstitial connective tis- 
sue was strongly positive, but the glomerular endo- and epi- 
Discussion 
Some of the CS residues produced by human lung fibroblasts 
are closely associated with the outer aspect of the plasma 
membrane (1,  18). The present results document that some 
CSPGs  of cultured human  lung fibroblasts indeed behave 
like integral membrane components, and that one form of 
these lipophilic CSPGs can be traced, in vitro during isola- 
tion procedures and in situ at the cell surface, by a murine 
monoclonal antibody which defines an epitope within the 90- 
kD core protein of this proteoglycan. 
The cell  surface exposure (Fig.  10)  and  the  lipophilic 
properties (Fig. 5) of the CSPG which is marked by the 7D8 
epitope, are two of the criteria which tentatively identify this 
proteoglycan as  an "integral" membrane molecule.  Unre- 
ported investigations have,  in  addition,  indicated that the 
7D8 epitope can be extracted as a micellar aggregate when 
whole fibroblasts or (placenta) plasma membrane fractions 
are exposed to 4  M  GdnHCI buffer without detergent, and 
that it becomes included in Sepharose CL4B columns when 
this extract is treated with detergent. Possibly, this proteogly- 
can is only one of several integral membrane CSPGs present 
in fibroblasts, as, indeed, the final preparation of hydropho- 
bic CSPGs contains multiple core protein bands (Fig. 6) of 
which only one could be shown to react with the 7D8 mAb 
(Figs. 6 and 7). The larger minor bands could, however, also 
represent glycosylation variants of the 90-kD core protein 
which are not sufficiently abundant for ready detection in 
Western blots, whereas the bands of lower relative molecular 
mass may represent core proteins which became truncated 
during isolation and have lost the epitope. If such were the 
case, it would mean that the 7D8 epitope is situated more dis- 
tally on the core protein with respect to the hydrophobic 
membrane anchor, than the chondroitin sulfate chains. The 
issue  of whether only one or  several  integral membrane 
CSPG species may occur in these cells needs further clari- 
fication. 
In the presence of  detergent, the overall size of the integral 
membrane CSPGs resembles that of  the small iduronic acid- 
rich CSPGs which constitute major fibroblast secretion prod- 
ucts (14).  Based on cDNA sequencing data (24) these pro- 
teoglycans seem to lack the necessary intrinsic properties of 
hydrophobicity to become directly embedded in the mem- 
brane. They are, however, subject to continuous internaliza- 
tion  through  a  process  of receptor-mediated endocytosis 
which involves a lysine recognition marker on the proteogly- 
can core protein (15),  so that these  CSPGs  may,  at  least 
temporarily, become peripherally membrane associated.  It 
seems possible that some of the Sepharose-included CSPGs 
David et al. Cell Surface Chondroitin Sulfate Proteoglycan  1171 Figure 10. Monoclonal antibody 7D8 decorates the cell surface of cultured human fibroblasts. (.4) Cultured human lung fibroblasts and, 
(B) HBL-100 cells were fixed, stained with mAb 7D8 using an indirect immunoperoxidase technique, and inspected in light microscopy. 
(C) Ultracryosections of cultured human fibroblasts were labeled with mAb 7D8 using an indirect immunogold technique, and analyzed 
in transmission electron microscopy. (D and E) Human lung fibroblasts were allowed to adhere and spread on a fibronectin coat for 90 
rain and fixed. Control cells (D) were labeled with gold-labeled goat anti-mouse Ig only, before silver enhancement. Others (E) were 
labeled with mAb 7D8 and gold-linked  goat anti-mouse Ig followed by silver enhancement, and analyzed by scanning electron microscopy. 
Binding of mAb 7D8 to the cells was also assessed in the presence of competing DEAE-beads (F), of DEAE-bound CSPG (G), and of 
DEAE-bound HSPG (H). Bars: (.4 and B)  100 #m; (D and E)  10/~m;  (C, F, G and H)  1 /~m. 
The Journal of Cell Biology,  Volume 108, 1989  1172 Figure 11. Tissue distribution of the 7D8 epitope. (A) Human skin, (B) liver, and (C) kidney cryosections were treated with mAb 7D8 
and stained using an indirect immunoperoxidase  technique and analyzed in light microscopy. (D) A human epidermal cell, stained with 
mAb 7D8 using an indirect immunoperoxidase  technique, and (E) a human fibroblast, decorated with mAb 7D8 and gold-labeled goat 
anti-mouse Ig, viewed in transmission electron microscopy. Bar: (A, B, and C) 100 #m; (D and E) 1 #m. 
present in extracts of fibroblast membranes (Fig.  1 B) may 
represent such receptor-bound proteoglycans, but it is un- 
likely that, under the dissociative conditions used for chro- 
matography, receptor-bound proteoglycans would contami- 
nate the micellar aggregates (or liposomes) which remain 
excluded from the columns. Moreover, the dimension of at 
least  the  7D8-positive  core  protein  largely  exceeds  that 
known for the core proteins in these secreted CSPGs. After 
chondroitinase digestion the core moieties of the latter show 
some heterogeneity due to the variable substitution of a 38- 
kD protein with two or three N-linked oligosaccharides and 
two to four CS chains (14), with core sizes (44--46 kD) that 
are only half of that obtained for the 7D8-positive core, but 
close to that of the smaller 7D8-negative hydrophobic cores 
(see also Fig. 9 B). However, none of the hydrophobic cores 
reacts  with antibodies raised against the core proteins  of 
these secreted proteoglycans (Fig. 9, A and B). Finally, com- 
paring  the  susceptibility of the  CSPGs to chondroitinase 
ABC and chondroitinase AC  suggested that the small se- 
creted forms are iduronic acid-rich (not shown), while the 
hydrophobic CSPGs are glucuronic acid-rich (Fig. 4). Thus, 
the integral membrane CSPGs and the small secreted CSPGs 
of human lung fibroblasts likely represent distinct molecular 
species. The nonlipophilic CSPGs of the detergent extracts, 
in contrast, display structural, functional, and immunologi- 
cal characteristics very reminiscent of those of the secreted 
CSPGs (Figs.  8 and 9). 
Immunohistochemistry  indicates that the expression of  the 
7D8 epitope is not restricted to human fibroblasts (Figs.  10 
and 11). Cell surface CSPGs have, in fact, also been reported 
in other cell types, including cultured rat ovarian granulosa 
cells (40),  human melanoma cells (3,  12),  B lymphocytes 
(13,  32),  and neurites  (4).  In some cells the cell surface 
CSPGs even appear to be hybrid proteoglycans and carry 
both heparan sulfate and chondroitin sulfate chains (8). Based 
on the apparent sizes of their core proteins, on their general 
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sue distribution of some of them, all these CSPGs seem to 
represent different molecular species.  Cell surface proteo- 
glycan complexity appears further enhanced by the observa- 
tion that at least some core proteins may also have alternative 
existences. The class II-associated CSPGs in lymphocytes 
indeed represent alternatively processed  forms of the  in- 
variant chain proteins  (13),  whereas the precursor of the 
melanoma core protein may bypass the glycosaminoglycan 
assembly step and exist at the cell surface as a 250-kD glyco- 
protein (16). Positive histochemical findings do therefore not 
necessarily imply that the detected epitopes are expressed as 
part of proteoglycans. During the fractionation of cultured 
fibroblasts and HBL-100 cells, at least, and within the limits 
of the sensitivity of the blotting assays, all of the 7D8 epitope 
appeared proteoglycan associated (not shown), which would 
distinguish this CSPG from the category of"occasional" pro- 
teoglycans. 
The functions of these cell surface CSPGs are not pre- 
cisely  known,  and  the  apparent  multiplicity of possible 
forms implies that these functions may be equally varied. In- 
terfering with the substitution of  the invariant chains with CS 
chains depresses the sensitization of target cells, consistent 
with a proposal that the proteoglycan form of the molecule 
may have a role in antigen processing or presentation (31). 
The membrane CSPG isolated from the electric organ, on 
the other hand, is thought to anchor the nerve terminal to the 
synaptic basement membrane (4), and the concentration of 
the melanoma proteoglycan on microspikes, microdomains 
of the cell surface involved in the initial interactions of cells 
with their neighbors or with the substratum, is also sugges- 
tive for a possible role in cell contact and adhesive phenom- 
ena (12). The subcellular distribution of the 7D8 epitope in 
spreading fibroblasts (Fig. 10) is clearly not as restricted as 
that of the melanoma proteoglycan, possibly reflecting alter- 
native spreading mechanisms in these cells or alternative 
functions for this proteoglycan. Monoclonal antibody 7D8 
did also not interfere with the adhesion or the spreading of 
the fibroblasts (not shown). The spreading of melanoma cells 
on endothelial matrix, in contrast, is inhibited by a  mAb 
which reacts with the melanoma CSPG (3), but obviously 
the functional repercussions of mAb binding will very much 
depend on the function of the reactive epitopes. On the other 
hand, some cell surface CSPGs may participate in pericellu- 
lar processes  involving soluble ligands. The activation of 
heparin cofactor II by human fibroblasts and the concomitant 
inhibition of thrombin, for example, seems primarily due to 
the presence of some low relative molecular mass chondroi- 
tinase ABC-sensitive proteoglycans in the fibroblast mono- 
layers  (29).  Since  thrombin  is  mitogenic for  fibroblasts, 
CSPGs of the cell surface with heparin cofactor activating 
effects could be involved in the modulation of tissue repair 
responses. Further investigations and the development of ad- 
ditional tools will be required, however, to clarify the func- 
tion of the membrane CSPGs of human lung fibroblasts and 
to clarify their relationship to the membrane CSPGs of other 
cell types. 
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